| Literature DB >> 21604797 |
Krishnan K Palaniappan1, Austin A Pitcher, Brian P Smart, David R Spiciarich, Anthony T Iavarone, Carolyn R Bertozzi.
Abstract
Directed proteomics applies mass spectrometry analysis to a subset of information-rich proteins. Here we describe a method for targeting select proteins by chemical modification with a tag that imparts a distinct isotopic signature detectable in a full-scan mass spectrum. Termed isotopic signature transfer and mass pattern prediction (IsoStamp), the technique exploits the perturbing effects of a dibrominated chemical tag on aEntities:
Mesh:
Substances:
Year: 2011 PMID: 21604797 PMCID: PMC3220624 DOI: 10.1021/cb100338x
Source DB: PubMed Journal: ACS Chem Biol ISSN: 1554-8929 Impact factor: 5.100
Figure 1The IsoStamp method improves shotgun proteomics by allowing tagged peptides to be detectable in full-scan mass spectra, facilitating an inclusion-list-driven directed LC–MS/MS experiment. (a) A mixture of proteins where some are chemically tagged (star) is subjected to proteolytic digestion producing (b) a mixture of peptides. (c) Peptides are separated using LC, and full-scan mass spectra are collected. (d) Tagged peptides are identified using a pattern-searching algorithm and inventoried into an (e) inclusion list (rt = retention time). (f1–3) The same sample is then subjected to a directed LC–MS/MS experiment where (f3) MS/MS analysis is only performed on (f2) precursor ions defined in the inclusion list. (g) Data are finally subjected to a database search for parent protein identification
Figure 2Halogenated tags impart distinct isotopic patterns on peptides. (a) Iodoacetamide-derivatized halogen tags synthesized from tyrosine. (b) Mass spectra of the halogen tags. (c) In a model experiment, BSA was alkylated on cysteine residues with iodoacetic acid or halogen tags 1–4 and then digested with trypsin. (d) Mass spectra of the modified BSA tryptic peptide corresponding to residues 89–100. C* refers to a cysteine residue alkyated by either iodoacetic acid or tags 1–4.
Figure 3The dibromide motif can be recognized at low signal-to-noise ratios. (a) Representative full-scan mass spectrum from LC–MS data derived from a trypsin digest of 150 fmol of dibromide-labeled BSA in 10 μg of Jurkat whole cell lysate. (b) The zoomed-in region shows a dibromide-labeled peptide (in black) LKPDPNTLC*DEFK at a S/N of 2.5:1. C* refers to a cysteine residue alkylated with dibromide tag 1.
Figure 4The dibromide motif is superior to other halogen motifs with respect to the number of false positives and sensitivity. (a) Number of false positives identified in Jurkat whole cell lysate without BSA using searching conditions that found 50% of true positives for each halogen tag. (b) Sensitivity engendered by each halogen tag was determined by titrating 3.0–0.03 pmol of halogen-labeled BSA into 10 μg of Jurkat whole cell lysate and analyzing the tryptic digest by LC–MS.
Figure 5IsoStamp with the dibromide tag in a model directed shotgun proteomics experiment. (a) The isotopic envelope of a precursor ion that was selected for fragment ion (m/z = 883.26, highlighted in blue) and its isolation window (highlighted in yellow). (b) The CID fragmentation spectra and the peptide assignment for the 883.26 ion, indicating that it is a dibromide-labeled BSA peptide (C* refers to a cysteine residue alkylated with dibromide tag 1). (c) The y+ fragmention ion, which contains the dibromide tag, also displays a perturbed isotopic envelope. (d) Numbers of unique peptides detected using the data-dependent and the directed approaches. The indicated amounts of BSA were added to 10 μg of Jurkat whole cell lysate prior to digestion and LC–MS/MS analysis.